News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
279,610 Results
Type
Article (15245)
Company Profile (296)
Press Release (264069)
Section
Business (84511)
Career Advice (315)
Deals (14570)
Drug Delivery (39)
Drug Development (53594)
Employer Resources (35)
FDA (6398)
Job Trends (5829)
News (154782)
Policy (11019)
Tag
Academia (967)
Alliances (22702)
Alzheimer's disease (755)
Antibody-drug conjugate (ADC) (53)
Approvals (6377)
Artificial intelligence (64)
Bankruptcy (107)
Best Places to Work (5158)
Biotechnology (243)
Breast cancer (80)
Cancer (786)
Cardiovascular disease (64)
Career advice (266)
CAR-T (59)
Cell therapy (181)
Clinical research (42739)
Collaboration (255)
Compensation (99)
COVID-19 (1091)
C-suite (70)
Cystic fibrosis (68)
Data (841)
Diabetes (80)
Diagnostics (1419)
Earnings (31789)
Events (48687)
Executive appointments (193)
FDA (6712)
Funding (256)
Gene editing (58)
Gene therapy (149)
GLP-1 (318)
Government (1204)
Healthcare (7190)
Infectious disease (1128)
Inflammatory bowel disease (94)
IPO (7788)
Job creations (943)
Job search strategy (238)
Layoffs (194)
Legal (1582)
Lung cancer (126)
Manufacturing (81)
Medical device (3239)
Medtech (3240)
Mergers & acquisitions (6888)
Metabolic disorders (238)
Neuroscience (968)
NextGen Class of 2024 (2269)
Non-profit (965)
Northern California (979)
Obesity (129)
Opinion (108)
Parkinson's disease (61)
Patents (56)
People (25732)
Pharmaceutical (51)
Phase I (14409)
Phase II (19554)
Phase III (13334)
Pipeline (340)
Postmarket research (1040)
Preclinical (6019)
Radiopharmaceuticals (213)
Rare diseases (171)
Real estate (1555)
Regulatory (8913)
Research institute (990)
Southern California (883)
Startups (2003)
United States (7965)
Vaccines (189)
Weight loss (83)
Date
Today (1)
Last 7 days (430)
Last 30 days (2257)
Last 365 days (21757)
2024 (20003)
2023 (23474)
2022 (28099)
2021 (29199)
2020 (24930)
2019 (17944)
2018 (13126)
2017 (14699)
2016 (12812)
2015 (15462)
2014 (11224)
2013 (8132)
2012 (8288)
2011 (8442)
2010 (8112)
Location
Africa (171)
Asia (17643)
Australia (3130)
California (2218)
Canada (756)
China (179)
Colorado (87)
Connecticut (88)
Europe (38961)
Florida (240)
Georgia (63)
Illinois (136)
Indiana (62)
Kansas (59)
Maryland (315)
Massachusetts (1749)
Minnesota (103)
New Jersey (600)
New York (632)
North Carolina (414)
Northern California (979)
Ohio (84)
Pennsylvania (443)
South America (246)
Southern California (883)
Texas (246)
Washington State (228)
279,610 Results for "plus therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Plus Therapeutics and SpectronRx Announce Radiotherapeutic Manufacturing Partnership
Partnership will expand Plus’ capability to meet late-stage clinical and commercial forecasts for Rhenium (186Re) Obisbemeda and reinforce supply chain redundancy
November 6, 2024
·
3 min read
Press Releases
Plus Therapeutics and SpectronRx Announce Radiotherapeutic Manufacturing Partnership
November 6, 2024
·
8 min read
Press Releases
Plus Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights
November 15, 2024
·
13 min read
Business
Plus Therapeutics Expands Management Team and Reports $3.3M Advance Payment from CPRIT
Plus Therapeutics, Inc. announced the appointment of Dr. Greg Fuller as the Company’s Vice President of Medical Affairs and Medical Director.
June 7, 2024
·
10 min read
Lone Star Bio
Plus Therapeutics Announces New Employment Inducement Grants - May 17, 2024
Plus Therapeutics, Inc. announced that on May 8, 2024, it granted option awards to Charles Huang, the Company’s new Director of Capital Markets and Investor Relations.
May 17, 2024
·
2 min read
Press Releases
Plus Therapeutics to Present Multi-Institutional Experience Using the CNSide™ Cerebrospinal Fluid Assay in Patients with Leptomeningeal Metastases
November 21, 2024
·
8 min read
Press Releases
Plus Therapeutics Showcases Leptomeningeal Metastases Programs at the 2024 SNO Annual Meeting in Houston, Texas
October 29, 2024
·
8 min read
Press Releases
Plus Therapeutics to Announce Third Quarter Financial Results and Host Conference Call on November 14, 2024
November 5, 2024
·
4 min read
Lone Star Bio
Plus Therapeutics Provides Highlights Regarding Leptomeningeal Metastases Acquisition and Topline Clinical Trial Data on the FORESEE Trial
Plus Therapeutics, Inc. (Nasdaq: PSTV) (“Plus” or the “Company”) provided highlights from its investor call regarding the rationale for the acquisition of the leptomeningeal metastases diagnostic platform “CNSide” and topline data from the FORESEE clinical trial.
May 9, 2024
·
9 min read
Business
Plus Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”) today announced financial results for the first quarter ended March 31, 2024, and provided an overview of recent and upcoming business highlights.
May 15, 2024
·
13 min read
1 of 27,961
Next
